The in vitro activity of HR 756 was compared with penicillin, cefamandole, cefoxitin, and tetracycline against Neisseriagonorrhoeae. A total of 192 randomly selected isolates (of which 23 had minimal inhibitory concentrations of -0.5 jig/ ml for penicillin) and three (t-lactamase-producing isolates were tested. HR 756 was the most active antibiotic tested, with more than 90% of the isolates inhibited by 0.008 ,ug/ml and all inhibited by 0.25 ,ug/ml.Infection with Neisseria gonorrhoeae is the most commonly reported communicable disease in the United States. Although penicillin is still the best antibiotic, in recent years an increasing number of isolates of N. gonorrhoeae have become resistant to this agent (6,7,9,12,16 We have previously reported that HR 756, a new cephalosporin antibiotic, was very active against both gram-positive and gram-negative bacteria (14). In addition Fu and Neu (4) have shown that HR 756 was not hydrolyzed by the Richmond types I, III, IV, and V ,B-lactamases.In the present study, we have tested the activity of HR 756 against randomly selected clinical isolates and several fB-lactamase-producing isolates of N. gonorrhoeae and compared the activity of this new cephalosporin with the activities of penicillin G, cefamandole, cefoxitin, and tetracycline.MATERLS